Endocrine treatment of prostate cancer - recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side-effects.
Schröder
F H
FH
Department of Urology, Erasmus University and Academic Hospital Rotterdam, The Netherlands.
D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000209:etiology; D005544:Forecasting; D006801:Humans; D007989:Libido; D008297:Male; D015201:Meta-Analysis as Topic; D009919:Orchiectomy / Q000009:adverse effects; D011471:Prostatic Neoplasms / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic
D000726:Androgen Antagonists; D000970:Antineoplastic Agents